Skip to main content

RT @RichardPAConway: Baraliakos et al. AEs with SC vs IV infliximab. Relatively comparable safety profiles. Higher admin

Nov 14, 2022 9:17 am
Social Author Name
Richard Conway
Tweet Content
Baraliakos et al. AEs with SC vs IV infliximab. Relatively comparable safety profiles. Higher administration site reactions in SC. @RheumNow #ACR22 Abstr#1769 https://t.co/KnYlvifDlr https://t.co/VnKOYs86Xz
Show on Archive Page
On
Display in Search Results
On
PDQ
Off
×